77 related articles for article (PubMed ID: 16753976)
1. Methods to rapidly and accurately screen a large number of ENU mutagenized mice for abnormal motor phenotypes.
Abramow-Newerly W; Lipina T; Abramow-Newerly M; Kim D; Bechard AR; Xie G; Clapcote SJ; Roder JC
Amyotroph Lateral Scler; 2006 Jun; 7(2):112-8. PubMed ID: 16753976
[TBL] [Abstract][Full Text] [Related]
2. ENU mutagenesis screening for dominant behavioral mutations based on normal control data obtained in home-cage activity, open-field, and passive avoidance tests.
Wada Y; Furuse T; Yamada I; Masuya H; Kushida T; Shibukawa Y; Nakai Y; Kobayashi K; Kaneda H; Gondo Y; Noda T; Shiroishi T; Wakana S
Exp Anim; 2010; 59(4):495-510. PubMed ID: 20660996
[TBL] [Abstract][Full Text] [Related]
3. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
4. A genetic screen for novel behavioral mutations in mice.
Sayah DM; Khan AH; Gasperoni TL; Smith DJ
Mol Psychiatry; 2000 Jul; 5(4):369-77. PubMed ID: 10889547
[TBL] [Abstract][Full Text] [Related]
5. A genomewide screening of N-ethyl-N-nitrosourea-mutagenized mice for musculoskeletal phenotypes.
Srivastava AK; Mohan S; Wergedal JE; Baylink DJ
Bone; 2003 Aug; 33(2):179-91. PubMed ID: 14499351
[TBL] [Abstract][Full Text] [Related]
6. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral mutants identified in an ENU-mutagenesis project.
Cook MN; Dunning JP; Wiley RG; Chesler EJ; Johnson DK; Miller DR; Goldowitz D
Mamm Genome; 2007 Aug; 18(8):559-72. PubMed ID: 17629744
[TBL] [Abstract][Full Text] [Related]
8. Disease progression of human SOD1 (G93A) transgenic ALS model rats.
Matsumoto A; Okada Y; Nakamichi M; Nakamura M; Toyama Y; Sobue G; Nagai M; Aoki M; Itoyama Y; Okano H
J Neurosci Res; 2006 Jan; 83(1):119-33. PubMed ID: 16342121
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit.
Kuner R; Groom AJ; Müller G; Kornau HC; Stefovska V; Bresink I; Hartmann B; Tschauner K; Waibel S; Ludolph AC; Ikonomidou C; Seeburg PH; Turski L
Ann N Y Acad Sci; 2005 Aug; 1053():269-86. PubMed ID: 16179532
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hemizygous SOD1/wild-type transgenic mice with the SHIRPA primary screen and tests of sensorimotor function and anxiety.
Lalonde R; Dumont M; Paly E; London J; Strazielle C
Brain Res Bull; 2004 Sep; 64(3):251-8. PubMed ID: 15464862
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 9 deficiency impacts sensory and motor behaviors.
Khariv V; Pang K; Servatius RJ; David BT; Goodus MT; Beck KD; Heary RF; Elkabes S
Brain Behav Immun; 2013 Aug; 32():164-72. PubMed ID: 23624295
[TBL] [Abstract][Full Text] [Related]
12. Exploratory activity and motor coordination in wild-type SOD1/SOD1 transgenic mice.
Lalonde R; Le Pêcheur M; Strazielle C; London J
Brain Res Bull; 2005 Jul; 66(2):155-62. PubMed ID: 15982533
[TBL] [Abstract][Full Text] [Related]
13. Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis.
Amendola J; Verrier B; Roubertoux P; Durand J
Eur J Neurosci; 2004 Nov; 20(10):2822-6. PubMed ID: 15548226
[TBL] [Abstract][Full Text] [Related]
14. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
15. Testicular development and fertility of mice treated prenatally with N-nitroso-N-ethylurea at various gestational stages.
Nagao T; Sato M; Marumo H; Shibuya T; Imai K
Teratog Carcinog Mutagen; 1996; 16(3):183-98. PubMed ID: 8983120
[TBL] [Abstract][Full Text] [Related]
16. Optimizing screening and mating strategies for phenotype-driven recessive N-ethyl-N-nitrosourea screens in mice.
Barbaric I; Dear TN
J Am Assoc Lab Anim Sci; 2007 Nov; 46(6):44-9. PubMed ID: 17994672
[TBL] [Abstract][Full Text] [Related]
17. Screening for ENU-induced mutations in mice that result in aberrant ethanol-related phenotypes.
Hamre KM; Goldowitz D; Wilkinson S; Matthews DB
Behav Neurosci; 2007 Aug; 121(4):665-78. PubMed ID: 17663592
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.
Srivastava AK; Kapur S; Mohan S; Yu H; Kapur S; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Jun; 20(6):1041-50. PubMed ID: 15883645
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis.
Furuse T; Wada Y; Hattori K; Yamada I; Kushida T; Shibukawa Y; Masuya H; Kaneda H; Miura I; Seno N; Kanda T; Hirose R; Toki S; Nakanishi K; Kobayashi K; Sezutsu H; Gondo Y; Noda T; Yuasa S; Wakana S
Eur J Neurosci; 2010 Apr; 31(7):1281-91. PubMed ID: 20345915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
